Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00616395 · ClinicalTrials.gov registry record
Study of Early Infant Diet on Growth and Development
A clinical trial, sponsored by Arkansas Children's Hospital Research Institute.
- Completed
- Registry status
- 600
- Enrollment target
NCT00616395: Completed study, sponsored by Arkansas Children's Hospital Research Institute.
NCT00616395 is a clinical trial that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00616395 has completed, sponsored by Arkansas Children's Hospital Research Institute.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize physical growth, body composition, dietary intake, neurobehavioral development, and brain function of infants and children fed mostly breast-milk, milk-based formula or soy-based formula during their first year of life. Children are followed from age 2 months to age 6 years.
Interventions
- DEVICE No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2002-09 |
| Est. Completion | 2025-06 |
What the finished NCT00616395 record still lists
NCT00616395 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT00616395 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00616395 about?
NCT00616395 is a clinical study titled "Study of Early Infant Diet on Growth and Development". The purpose of this study is to characterize physical growth, body composition, dietary intake, neurobehavioral development, and brain function of infants and children fed mostly breast-milk, milk-based formula or soy-based formula during their first year of life. Children are followed from age 2 mo...
What is the current status of trial NCT00616395?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2002-09. Estimated completion is 2025-06.
What interventions are being tested in trial NCT00616395?
The interventions under investigation include: No intervention (DEVICE).
Who is sponsoring clinical trial NCT00616395?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia